Back to EPRX

Affinity Asset Advisors, LLC → EPRX

Affinity Asset Advisors, LLC EPRX Position History

Eupraxia Pharmaceuticals Inc. • Healthcare

Quarters held
4
Latest value
$15.6M
Q3 2026
Peak value
$15.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$2.3M
Q1 2026$11.5M
Q2 2026$10.9M
Q3 2026$15.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$15.6M1.72M——
Q2 2026$10.9M1.65M——
Q1 2026$11.5M1.59M——
Q4 2025$2.3M300.0K——

Other funds holding EPRX

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M